Telaprevir is an HCV NS3/4A protease inhibitor used in combination with peginterferon and ribavirin for the treatment of chronic hepatitis C infection. In pharmaceutical development and quality control,… Read more
Telaprevir is an HCV NS3/4A protease inhibitor used in combination with peginterferon and ribavirin for the treatment of chronic hepatitis C infection. In pharmaceutical development and quality control, access to high-quality reference standards is essential for the accurate identification and quantification of the active pharmaceutical ingredient. Laboratories rely on this range of Telaprevir reference materials, which includes pharmacopeial and non-pharmacopeial impurities, to perform rigorous impurity profiling and ensure compliance with regulatory standards. Furthermore, stable isotope labelled compounds, such as deuterium-labelled Telaprevir, serve as critical internal standards for mass spectrometry-based bioanalytical assays, improving precision in method validation and pharmacokinetic studies. By utilizing these characterized standards, researchers can effectively monitor degradation products and verify the purity of drug batches, supporting the development and manufacturing of safe and effective antiviral therapies.